F. Gamarra (Straubing, Germany), A. Szpechcinski (Warszawa, Poland), D. Kauffmann-guerrero (Munich, Germany), I. Kwiecien (Warszawa, Poland)
The efficacy of Ado-trastuzumab emtansine in HER-2 aberrant non-small cell lung cancer
Y. Xia (Hangzhou, China), X. Huang (Hangzhou, China), R. Jin (Hangzhou, China), W. Li (Hangzhou, China), H. Shen (Hangzhou, China)
|  |
Completion pneumectomy is a safe procedure for non-small cell lung cancer
S. Guinard (Strasbourg, France), A. (Strasbourg, France), M. (Besançon, France), J. Seitlinger (Strasbourg, France), P. (Strasbourg, France), G. Massard (Strasbourg, France)
|  |
SCLC stage limited and very limited Disease with and without operation
M. Lavae-Mokhtari (Ibbenbueren, Germany), A. Akil (Ibbenbueren, Germany), D. Wehde (Ibbenbueren, Germany), M. Semik (Ibbenbueren, Germany), S. Fischer (Ibbenbueren, Germany), N. Dickgreber (Ibbenbueren, Germany)
| |
Comparison of different treatment modalities of NSCLC with chest wall infiltration - a retrospective monocentric observational Study
I. Jovanovic (Berlin, Germany), T. Blum (Berlin, Germany), J. Kollmeier (Berlin, Germany), D. Misch (Berlin, Germany), T. Mairinger (Berlin, Germany), A. Streubel (Berlin, Germany), S. Stephan-Falkenau (Berlin, Germany), G. Förster (Berlin, Germany), L. Moser (Berlin, Germany), T. Bauer (Berlin, Germany), J. Pfannschmidt (Berlin, Germany)
| |
Molecular testing in central lung cancer – endobronchial ultrasound-guided transbronchial needle aspiration and circulating tumor DNA analysis compared to endobronchial forceps biopsy
L. Hagmeyer (Solingen, Germany), S. Schäfer (Cologne, Germany), J. Fassunke (Cologne, Germany), A. Pietzke-Calcagnile (Solingen, Germany), M. Treml (Solingen, Germany), S. Herkenrath (Solingen, Germany), R. Büttner (Cologne, Germany), W. Randerath (Solingen, Germany)
| |
Location of three mediastinal lymph node stations in a three-dimensional model.
Ø. Yksnøy (Aalesund, Norway), D. Hoff (Aalesund, Norway), B. Grønberg (Trondheim, Norway), S. Sørhaug (Trondheim, Norway), K. Roth (Aalesund, Norway)
| |
Chronotropic incompetence in patients before lung cancer surgery
M. Sova (Olomouc, Czech Republic), A. Ghazal Asswad (Olomouc, Czech Republic), S. Genzor (Olomouc, Czech Republic), V. Kolek (Olomouc, Czech Republic)
| |
Role of Elastography during EBUS-TBNA in the determination of lymph node rigidity as a predictive tool of malignancy and benignity
C. Guarino (Napoli, Italy), C. Cesaro (Napoli, Italy), E. Zamparelli (Napoli, Italy), I. Pedicelli (Napoli, Italy), N. De Rosa (Napoli, Italy), G. La Cerra (Napoli, Italy)
| |
Mediastinal Lymph node echographic morphology for the prediction of malignancy in EBUS-TBNA
F. Aguiar (Braga, Portugal), F. Viana Machado (Porto, Portugal), G. Fernandes (Porto, Portugal), A. Magalhães (Porto, Portugal)
| |
Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center.
D. Spyratos (Thessaloniki, Greece), I. Tsiouprou (Thessaloniki, Greece), V. Tsartsianidou (Thessaloniki, Greece), S. Lampaki (Thessaloniki, Greece), E. Eleftheriadou (Thessaloniki, Greece), K. Domvri (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece)
| |
Performance of ROS1 fusion gene test using FFPE tissue and bronchoscopic cytologic specimen
K. Tsuji (Sapporo, Japan), N. Shinagawa (Sapporo, Japan), H. Kitai (Sapporo, Japan), T. Ikari (Sapporo, Japan), M. Sato (Sapporo, Japan), H. Takahashi (Sapporo, Japan), M. Kunisaki (Sapporo, Japan), T. Shoji (Sapporo, Japan), Y. Takashima (Sapporo, Japan), M. Furuta (Sapporo, Japan), H. Mizugaki (Sapporo, Japan), H. Asahina (Sapporo, Japan), J. Kikuchi (Sapporo, Japan), E. Kikuchi (Sapporo, Japan), Y. Oi (Tokyo, Japan), S. Nakajo (Tokyo, Japan), K. Hatanaka (Sapporo, Japan), Y. Hatanaka (Sapporo, Japan), Y. Matsuno (Sapporo, Japan), J. Sakakibara (Sapporo, Japan)
| |
Preliminary diagnostic performance of probe-based confocal laser endomicroscopy for peripheral pulmonary nodules, a multicenter prospective registry trial
I. Shaheen (Augusta, United States of America), D. Wilson (Columbus, United States of America), R. Browning (Bethesda, United States of America), D. Arenberg (Ann Harbor, United States of America), A. CRITON (Paris, France), S. Khurana (Rochester, United States of America), M. Nead (Rochester, United States of America), R. Holladay (Shreveport, United States of America), A. Wellikoff (Rochester, United States of America)
| |
The utility of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) in Programmed Death Ligand-1 (PDL-1) analysis of Non-Small Cell Lung Cancer (NSCLC)
F. Hameed (Oxford, United Kingdom), A. Moore (Oxford, United Kingdom), A. Sykes (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom)
| |
Mutational status of advanced lung adenocarcinoma in a Portuguese cohort
J. Pinto (Porto, Portugal), C. Sousa (Porto, Portugal), N. Martins (Porto, Portugal), S. Teixeira (Braga, Portugal), A. Magalhães (Porto, Portugal), G. Fernandes (Porto, Portugal), V. Hespanhol (Porto, Portugal), H. Queiroga (Porto, Portugal), H. Novais E Bastos (Porto, Portugal)
| |
Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
C. C. Sousa (Porto, Portugal), J. Pinto (Porto, Portugal), N. Martins (Porto, Portugal), S. Teixeira (Braga, Portugal), A. Magalhães (Porto, Portugal), G. Fernandes (Porto, Portugal), V. Hespanhol (Porto, Portugal), H. Queiroga (Porto, Portugal), H. Novais Bastos (Porto, Portugal)
| |
Hippo Effector YAP regulates Autophagy key effector p62 in Lung Adenocarcinoma
C. Chung (Daejeon, Republic of Korea), J. Kim (Daejeon, Republic of Korea), D. Park (Daejeon, Republic of Korea), D. Lee (Daejeon, Republic of Korea), J. Lee (Daejeon, Republic of Korea), H. Park (Daejeon, Republic of Korea), D. Kang (Daejeon, Republic of Korea), Y. Kim (Daejeon, Republic of Korea)
| |
CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways
X. Liu (Shanghai , China), S. Xue (Shanghai , China), H. Jiang (Shanghai , China)
| |